GLRX3 and nasopharyngeal carcinoma: Studies on NPC and OSCC have reported in common that knockdown of GLRX3 inhibited cell proliferation and decreased the migration and invasion capacity of cancer cells by suppressing the epithelial-mesenchymal transition, indicating the essential roles of GLRX3 in cancer progression25,26.